NCT01490216

Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence

Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence

• Status: Terminated
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving.

Detailed description

Evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving as determined by self-report and cocaine-positive urine samples.

Conditions

• Cocaine Dependence

Interventions

Type	Name	Description
DRUG	lisdexamfetamine	20mg q.d. to 70mg b.i.d

Timeline

• Start date: 2011-07-01
• Primary completion: 2013-01-01
• Completion: 2013-01-01
• First posted: 2011-12-12
• Last updated: 2019-07-15

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study